Galactogogues and breastfeeding
- 136 Downloads
- 2 Citations
Abstract
Reduced breast milk production (called hypogalactia) is the most frequent cause of breastfeeding failure. For this reason, physicians need to provide information regarding best practices for breastfeeding and, if necessary, they should indicate methods to support breast milk production, for example the use of galactogogue medications, making sure that these problems do not lead to cessation of breastfeeding. Galactogogues are synthetic or plants molecules able to induce, maintain and increase milk production in women. The most frequently used natural galactogogue products include galega and silymarin. Unfortunately, all herbal extracts are characterised by low solubility with poor bioavailability and for this reason, in order to increase the absorption and efficacy of silymarin, a new formulation was developed and used as a delivery system: Silitidil®, a phytosome composed of silymarin and phospholipids. Silitidil® is able to improve the bioavailability of silymarin, in comparison with pure silymarin and micronised silymarin. Moreover, a recently published pharmacological study from Capasso et al. has evaluated the effect of Silitidil ® and the association of Silitidil® plus Galega officinalis on prolactin blood levels in mature female Wistar rats, versus control and micronised silymarin. Silitidil® plus Galega officinalis showed improved bioavailability and prolactin plasma levels compared with the oldest formulations of silymarin. Based on available data, this formulation could be considered a safe and effective natural product able to improve daily breast milk production in healthy women after delivery, without affecting milk quality.
Keywords
Breastfeeding woman stimulation of lactation galactogoguesPreview
Unable to display preview. Download preview PDF.
References
- 1.Zuppa AA, Sindico P, Orchi C, Carducci C, Cardiello V, Romagnoli C (2010) Safety and efficacy of galactogogues: substances that induce, maintain and increase breast milk production. J Pharm Pharmaceut Sci 13(2):162–174Google Scholar
- 2.Forinash AB, Yancey AM, Barnes KN, Myles TD (2012) The use of galactogogues in the breastfeeding mother. Ann Pharmacother 46(10):1392–1404CrossRefGoogle Scholar
- 3.Penagos-Tabares F, Bedoya-Jaramillo JV, Ruiz-Cortés ZT (2014) Pharmacological overview of galactogogues. Vet Med Int 2014:602894. doi: 10.1155/2014/602894 CrossRefGoogle Scholar
- 4.American Academy of Pediatrics (2012) Breastfeeding and the use of human milk. Pediatrics 3:827–841Google Scholar
- 5.Canadian Pediatric Society (1998) Clinical practice guidelines: nutrition for healthy term infants. J Paed Child Health 3:109–112Google Scholar
- 6.Britton C, McCormick FM, Renfrew MJ, Wade A, King SE (2007) Support for breastfeeding mothers. Cochrane Database Syst Rev 24(1):001141Google Scholar
- 7.McDonald SD, Pullenayegum E, Chapman B, Vera C, Giglia L, Fusch C, Foster G (2012) Prevalence and predictors of exclusive breastfeeding at hospital discharge. Obstet Gynecol 119(6):1171–1179CrossRefGoogle Scholar
- 8.Odom EC, Li R, Scanlon KS, Perrine CG, Grummer-Strawn L (2013) Reasons for earlier than desired cessation of breastfeeding. Pediatrics 131(3):726–732CrossRefGoogle Scholar
- 9.Chen DC, Nommsen-Rivers L, Dewey KG, Lönnerdal B (1998) Stress during labor and delivery and early lactation performance. Am J Clin Nutr 68:335–344Google Scholar
- 10.Chatterton RT Jr, Hill PD, Aldag JC, Hodges KR, Belknap SM, Zinaman MJ (2000) Relation of plasma oxytocin and prolactin concentrations to milk production in mothers of preterm infants: influence of stress. J Clin Endocrinol Metab 85(10):3661–3668Google Scholar
- 11.Mortel M, Mehta SD (2013) Systematic review of the efficacy of herbal galactogogues. J Hum Lact 29:154–162CrossRefGoogle Scholar
- 12.Turkyilmaz C, Onal E, Hirfanoglu IM (2011) The effect of galactagogue herbal tea on breast milk production and shortterm catch-up of birth weight in the first week of life. J Altern Complement Med 17(2):139–142CrossRefGoogle Scholar
- 13.Champavier Y, Allais DP, Chulia AJ, Kaouadji M (2000) Acetylated and non-acetylated flavonol triglycosides from Galega officinalis. Chem Pharm Bull (Tokyo) 48(2):281–282CrossRefGoogle Scholar
- 14.Karimi G, Vahabzadeh M, Lari P, Rashedinia M, Moshiri M (2011) “Silymarin”, a promising pharmacological agent for treatment of diseases. Iran J Basic Med Sci 14(4):308–317Google Scholar
- 15.Kesarwani K, Gupta R, Mukerjee A (2013) Bioavailability enhancers of herbal origin: an overview. Asian Pac J Trop Biomed 3(4):253–266CrossRefGoogle Scholar
- 16.Ajazuddin SS (2010) Applications of novel drug delivery system for herbal formulations. Fitoterapia 81:680–689CrossRefGoogle Scholar
- 17.Head KA, Kelly GS (2009) Nutrients and botanicals for treatment of stress: adrenal fatigue, neurotransmitter imbalance, anxiety, and restless sleep. Altern Med Rev 14(2):114–140Google Scholar
- 18.Starks MA, Starks SL, Kingsley M, Purpura M, Jäger R (2008) The effects of phosphatidylserine on endocrine response to moderate intensity exercise. J Int Soc Sports Nutr 5:11CrossRefGoogle Scholar
- 19.Zuppa AA. Allattamento al seno: novità in tema di galattogoghi. Atti XXV Congresso Nazionale SIPPS 2013. Pag.: 21–22Google Scholar
- 20.Capasso R (2014) Effect of Silitidil, a standardized extract of milk thistle, on the serum prolactin levels in female rats. Nat Product Commun 9(7):943–944Google Scholar
- 21.Di-Pierro F, Callegari A, Carotenuto D, Tapia MM (2008) Clinical efficacy, safety and tolerability of BIO-C (micronized Silymarin) as a galactagogue. Acta Biomed 79(3):205–210Google Scholar
- 22.Castoldi F, Pivetti V, Moiraghi L, Marangione P, Lista G (2014) [Silymarin/galega administration in term and preterm mothers to sustain breast feeding: an observational study]. Minerva Pediatr 66(5):375–380Google Scholar